because it requires significant alteration of the lipid composi-
tion. However, the effort to increase its therapeutic index,
namely, minimizing its high hemolytic activity while main-
taining its high antibiotic activity, has been hampered by
the limited number of accessible analogues of the natural
product through traditional synthetic methods.6
proved by the successful synthesis of tyrocidine A analogues
1
0
by TycC TE, an NRPS thioesterase homologous to GrsB
TE. Here we explore the activity of the gramicidin S
thioesterase toward linear precursor substrates on solid
support and test its suitability for solid-phase parallel
synthesis of the natural product analogues.
One way to circumvent this problem is to take advantage
of enzymes in gramicidin S biosynthesis for chemoenzymatic
analogue synthesis. The natural product is a cyclic decapep-
tide antibiotic composed of two repetitive pentapeptide units
The gramicidin S thioesterase gene was amplified from
B. breVis (ATCC 9999) genomic DNA and expressed in the
11
vector pFAB5c.His. The 34-kD thioesterase with a histidine
tag at the carboxy terminus was purified from an E. coli
host, using metal-chelating affinity chromatography and
anion-exchange column chromatography, in good yield (∼1.0
7
that is produced by Bacillus breVis. It is synthesized by a
thiol-template mechanism catalyzed by modular nonriboso-
8
-1
mal peptide synthases (NRPS) GrsA and GrsB. Of particular
mg L ) and high purity (>95% pure by SDS-PAGE). The
interest is the last functional domain of GrsB, which is
predicted to be a thioesterase (GrsB TE) responsible for
dimerizing the linear pentapeptide precursor generated by
the NRPS and then cyclizing the dimer head-to-tail to release
the product gramincidin S (Scheme 1).
expressed protein was tested active toward NAC-pentapep-
tide and pentapeptide dimer with a comparable kcat and K
as reported.
M
9
The fully deprotected biosynthetic decapeptide precursor
of gramicidin S (4a, Figure 1) was synthesized on TentaGel-
In its putative form, GrsB TE was found to retain the
dimerization and cyclization power toward the pentapep-
tide substrate (2) coupled to a N-acetylcysteaminyl (NAC)
group at carboxy terminus, a mimic of the native phospho-
pantetheinyl spacer linking the linear peptide and the peptidyl
carrier protein (PCP). However, the yields of the dimer and
the cyclic product were very low, whereas the hydrolysis of
9
the thioester dominated the enzyme-catalyzed reaction. The
abortive thioester hydrolysis was avoided when the linear
dimerized decapeptide precursor (3) was used directly as the
substrate for GrsB TE. In homogeneous solution, the enzyme
was further demonstrated to tolerate change in the linear
peptide sequence and be capable of cyclizing peptide
precursors with variable sizes. These investigations show the
potential of the thioester in parallel generation of the cyclic
peptide analogues for the natural product.
Figure 1. Structures of the linear precursors on TentaGel resin
for cyclization by GrsB TE.
The most efficient way to generate analogues of the natural
product is to use the thioesterase to cyclize an array of linear
decapeptide precursors through the combinatorial solid-phase
peptide synthesis (SPPS). Feasibility of this strategy has been
OH resin, using a modified Fmoc deprotection method for
12
solid-phase peptide synthesis. This precursor, similar to that
1
3
for tyrocidine A, was found to cyclize spontaneously into
head-to-tail product (1) in ammonia solution, providing a
convenient way to quantify the total amount of correct linear
decapeptide precursor.
(3) (a) Hodgkin, D. C.; Oughton, B. M. Biochem. J. 1957, 65, 752. (b)
Stern, A.; Gibbons, W. A.; Craig, L. C. Proc. Natl. Acad. Sci. U.S.A. 1968,
6
1
1, 734. (c) Ohnishi, M.; Urry, D. W. Biochim. Biophys. Res. Commun.
969, 36, 194.
(
4) Prenner, E. J.; Lewis, R. N. A. H.; McElhaney, R. N. Biochim.
Biophys. Acta 1999, 1462, 201.
To test the activity of the enzyme toward the solid-
supported substrate, freshly deprotected linear peptide on the
(
5) Hancock, R. E. W. Lancet 1997, 349, 418.
-
1
(6) Waki, M.; Izumiya, N. In Biochemistry of Peptide Antibiotics: Recent
resin (50 mg, loading 0.20 mmol g ) was extensively
washed with methanol and double-deionized water and
AdVances in the Biotechnology of â-Lactams and Microbial BioactiVe
Peptides; Kleinkaug, H., von D o¨ hren, H., Eds.; Walter de Gruyter: Berlin,
-
1
1
990, pp 205-244.
7) (a) Gause, G. G.; Brazhnikova, M. G. Nature 1944, 154, 703. (b)
immersed in 100 µL of the GrsB TE (100 µg mL ) in 25
mM 3-(N-morpholino)propanesulfonate (MOPS) buffer (pH
(
Izumiya, N.; Kato, T.; Aoyagi, H.; Waki, M.; Kondo M. In Synthetic Aspects
of Biologically ActiVe Cyclic Peptides-Gramicidin and Tyrocidines; Kodan-
sha Ltd. and Wiley: Tokyo, 1979.
7
.0) in a 1.5-mL microfuge tube. The suspension was
constantly swirled and incubated at 37 °C for 3 h. After the
incubation, the reaction was quenched by addition of 100
µL of 1.7% trifluoroacetic acid in H O. The resin was
2
separated from the supernatant and washed thrice with 1 mL
(
8) (a) Kr a¨ tzschmar, J.; Krause, M.; Marahiel, M. A. J. Bacteriol. 1989,
1
1
5
71, 5422. (b) Kleinkauf, H.; von D o¨ hren, H. Eur. J. Biochem. 1990, 192,
. (c) Turgay, K.; Krause, M.; Marahiel, M. A. Mol. Micriobiol. 1992, 6,
29. (d) Kleinkauf, H.; von D o¨ hren, H. Eur. J. Biochem. 1996, 236, 335.
(
2
9
e) von D o¨ hren, H.; Keller, U.; Vater, J.; Zocher, R. Chem. ReV. 1997, 97,
675. (f) Marahiel, M. A.; Stachelhaus, T.; Mootz, H. D. Chem. ReV. 1997,
7, 2661.
(10) Kohli, R. M.; Walsh, C. T.; Burkart, M. D. Nature 2002, 418, 658.
(11) Orum, H.; Andersen, P. S.; Oster, A.; Johansen, L. K.; Riise, E.;
Bjørnvad, M.; Svendsen, I.; Engberg, J. Nucleic Acids Res. 1993, 21, 4491.
(12) Bu, X.; Xie, G.; Law, C. W.; Guo, Z. Tetrahedron Lett. 2002, 43,
2419.
(9) (a) Trauger, J. W.; Kohli, R. M.; Mootz, H. D.; Marahiel, M. A.
Walsh, C. T. Nature 2000, 407, 215. (b) Trauger, J. W.; Kohli, R. M.;
Walsh, C. T. Biochemistry 2001, 40, 7092. (c) Kohli, R. M.; Trauger, J.
W.; Schwarzer, D.; Marahiel, M. A.; Walsh, C. T. Biochemistry 2001, 40,
7
099.
(13) Bu, X.; Wu, X.; Xie, G.; Guo, Z. Org. Lett. 2002, 4, 2893.
1750
Org. Lett., Vol. 5, No. 10, 2003